

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of protein activation cascade (GO:2000257) | 8.97181896 |
| 2 | regulation of complement activation (GO:0030449) | 8.61230000 |
| 3 | drug catabolic process (GO:0042737) | 8.33328938 |
| 4 | exogenous drug catabolic process (GO:0042738) | 8.08505132 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 7.56929099 |
| 6 | regulation of fibrinolysis (GO:0051917) | 7.53806573 |
| 7 | negative regulation of fibrinolysis (GO:0051918) | 7.20520712 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 7.07023534 |
| 9 | blood coagulation, intrinsic pathway (GO:0007597) | 6.94405212 |
| 10 | cellular glucuronidation (GO:0052695) | 6.61227364 |
| 11 | urea metabolic process (GO:0019627) | 6.51920984 |
| 12 | glucuronate metabolic process (GO:0019585) | 6.22708915 |
| 13 | uronic acid metabolic process (GO:0006063) | 6.22708915 |
| 14 | negative regulation of cholesterol transport (GO:0032375) | 6.07765742 |
| 15 | negative regulation of sterol transport (GO:0032372) | 6.07765742 |
| 16 | nitrogen cycle metabolic process (GO:0071941) | 6.02617512 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.98361827 |
| 18 | protein carboxylation (GO:0018214) | 5.98361827 |
| 19 | oxidative demethylation (GO:0070989) | 5.92204995 |
| 20 | fibrinolysis (GO:0042730) | 5.85014029 |
| 21 | bile acid biosynthetic process (GO:0006699) | 5.75625978 |
| 22 | protein activation cascade (GO:0072376) | 5.60439507 |
| 23 | urea cycle (GO:0000050) | 5.58756081 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.58537192 |
| 25 | L-phenylalanine catabolic process (GO:0006559) | 5.53039559 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.53039559 |
| 27 | glyoxylate metabolic process (GO:0046487) | 5.35401795 |
| 28 | negative regulation of protein activation cascade (GO:2000258) | 5.35232188 |
| 29 | imidazole-containing compound metabolic process (GO:0052803) | 5.32682455 |
| 30 | bile acid metabolic process (GO:0008206) | 5.25362312 |
| 31 | regulation of humoral immune response (GO:0002920) | 5.23748168 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 5.22602396 |
| 33 | complement activation (GO:0006956) | 5.16407291 |
| 34 | drug metabolic process (GO:0017144) | 5.12734301 |
| 35 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.01861902 |
| 36 | L-phenylalanine metabolic process (GO:0006558) | 5.01861902 |
| 37 | low-density lipoprotein particle remodeling (GO:0034374) | 4.97935797 |
| 38 | bile acid and bile salt transport (GO:0015721) | 4.97445354 |
| 39 | phospholipid efflux (GO:0033700) | 4.84148571 |
| 40 | arginine catabolic process (GO:0006527) | 4.82839146 |
| 41 | regulation of bile acid biosynthetic process (GO:0070857) | 4.80123795 |
| 42 | cholesterol efflux (GO:0033344) | 4.76312604 |
| 43 | complement activation, classical pathway (GO:0006958) | 4.74016928 |
| 44 | high-density lipoprotein particle remodeling (GO:0034375) | 4.73340749 |
| 45 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.71479526 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.70329142 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.70329142 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.70329142 |
| 49 | aromatic amino acid family catabolic process (GO:0009074) | 4.63664399 |
| 50 | phosphate ion transmembrane transport (GO:0035435) | 4.61481478 |
| 51 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 4.51505587 |
| 52 | glycine metabolic process (GO:0006544) | 4.47741978 |
| 53 | phospholipid homeostasis (GO:0055091) | 4.42820187 |
| 54 | reverse cholesterol transport (GO:0043691) | 4.40451507 |
| 55 | negative regulation of hemostasis (GO:1900047) | 4.36468686 |
| 56 | negative regulation of blood coagulation (GO:0030195) | 4.36468686 |
| 57 | serine family amino acid catabolic process (GO:0009071) | 4.26564295 |
| 58 | negative regulation of complement activation (GO:0045916) | 4.26137326 |
| 59 | arginine metabolic process (GO:0006525) | 4.19587172 |
| 60 | cytolysis (GO:0019835) | 4.14485522 |
| 61 | intestinal cholesterol absorption (GO:0030299) | 4.13173775 |
| 62 | regulation of apoptotic cell clearance (GO:2000425) | 4.11883110 |
| 63 | opsonization (GO:0008228) | 4.10949619 |
| 64 | acute-phase response (GO:0006953) | 4.06371900 |
| 65 | S-adenosylmethionine metabolic process (GO:0046500) | 4.03976189 |
| 66 | phosphate ion transport (GO:0006817) | 3.97452015 |
| 67 | alkaloid metabolic process (GO:0009820) | 3.95342698 |
| 68 | negative regulation of coagulation (GO:0050819) | 3.93634090 |
| 69 | regulation of triglyceride catabolic process (GO:0010896) | 3.93199588 |
| 70 | negative regulation of wound healing (GO:0061045) | 3.91752156 |
| 71 | flavonoid metabolic process (GO:0009812) | 3.86747078 |
| 72 | plasma lipoprotein particle assembly (GO:0034377) | 3.85737159 |
| 73 | indole-containing compound catabolic process (GO:0042436) | 3.84219812 |
| 74 | indolalkylamine catabolic process (GO:0046218) | 3.84219812 |
| 75 | tryptophan catabolic process (GO:0006569) | 3.84219812 |
| 76 | triglyceride homeostasis (GO:0070328) | 3.83020611 |
| 77 | acylglycerol homeostasis (GO:0055090) | 3.83020611 |
| 78 | regulation of hexokinase activity (GO:1903299) | 3.81760837 |
| 79 | regulation of glucokinase activity (GO:0033131) | 3.81760837 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 3.81702778 |
| 81 | glutamate metabolic process (GO:0006536) | 3.80360074 |
| 82 | plasma lipoprotein particle clearance (GO:0034381) | 3.78276126 |
| 83 | regulation of acute inflammatory response (GO:0002673) | 3.73182305 |
| 84 | response to vitamin A (GO:0033189) | 3.70924429 |
| 85 | regulation of plasminogen activation (GO:0010755) | 3.69510780 |
| 86 | negative regulation of lipase activity (GO:0060192) | 3.64552117 |
| 87 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.64431578 |
| 88 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.64431578 |
| 89 | plasma lipoprotein particle organization (GO:0071827) | 3.58469975 |
| 90 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.55911353 |
| 91 | amino-acid betaine metabolic process (GO:0006577) | 3.52541799 |
| 92 | alpha-linolenic acid metabolic process (GO:0036109) | 3.51160558 |
| 93 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.49035739 |
| 94 | positive regulation of hemostasis (GO:1900048) | 3.46839182 |
| 95 | positive regulation of blood coagulation (GO:0030194) | 3.46839182 |
| 96 | negative regulation of digestive system process (GO:0060457) | 3.40721614 |
| 97 | heme transport (GO:0015886) | 3.39120345 |
| 98 | alpha-amino acid catabolic process (GO:1901606) | 3.35431881 |
| 99 | protein-lipid complex assembly (GO:0065005) | 3.31610984 |
| 100 | complement activation, alternative pathway (GO:0006957) | 10.4973496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.35726522 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.94185452 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.17626736 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.66654663 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.32033211 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.15144305 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.78134043 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.23143168 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.13925782 |
| 10 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.75055595 |
| 11 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 2.46980532 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.39934580 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.33635826 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.31499184 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.22620273 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.20685341 |
| 17 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.17048540 |
| 18 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 2.00230414 |
| 19 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.97958132 |
| 20 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.92202772 |
| 21 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.76264250 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.75923404 |
| 23 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.68457000 |
| 24 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.63642197 |
| 25 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.63516806 |
| 26 | NFYA_21822215_ChIP-Seq_K562_Human | 1.63505568 |
| 27 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.61850606 |
| 28 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.59853592 |
| 29 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.58683595 |
| 30 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.57345575 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.55991302 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.54959239 |
| 33 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.50719239 |
| 34 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.46764722 |
| 35 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.46203963 |
| 36 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.45694516 |
| 37 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.44293309 |
| 38 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.42099244 |
| 39 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.41849186 |
| 40 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.41036293 |
| 41 | NFYB_21822215_ChIP-Seq_K562_Human | 1.39599185 |
| 42 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.37613329 |
| 43 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.36153360 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35710334 |
| 45 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.35664249 |
| 46 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.35256565 |
| 47 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.34148184 |
| 48 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.33620278 |
| 49 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.33485164 |
| 50 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.33405561 |
| 51 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.32749418 |
| 52 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.32551780 |
| 53 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.31434710 |
| 54 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.30912095 |
| 55 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.29178590 |
| 56 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.28789862 |
| 57 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.28233017 |
| 58 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.27947277 |
| 59 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.26611500 |
| 60 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.25910696 |
| 61 | TBL1_22424771_ChIP-Seq_293T_Human | 1.25196904 |
| 62 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.23458578 |
| 63 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.22657183 |
| 64 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21766512 |
| 65 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.21441466 |
| 66 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.21262320 |
| 67 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.20555161 |
| 68 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.17794024 |
| 69 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.16939980 |
| 70 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.16265428 |
| 71 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.15415382 |
| 72 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13764614 |
| 73 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12662682 |
| 74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09668814 |
| 75 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09208559 |
| 76 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.07871668 |
| 77 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.06541955 |
| 78 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.06541955 |
| 79 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04384826 |
| 80 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.04222704 |
| 81 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03155542 |
| 82 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97855590 |
| 83 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97284458 |
| 84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96879130 |
| 85 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95568655 |
| 86 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.95253373 |
| 87 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.91960611 |
| 88 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91163132 |
| 89 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.91052918 |
| 90 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90291024 |
| 91 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90291024 |
| 92 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89486250 |
| 93 | VDR_22108803_ChIP-Seq_LS180_Human | 0.87007572 |
| 94 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.86268574 |
| 95 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.83846404 |
| 96 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.83824785 |
| 97 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81768130 |
| 98 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.80803649 |
| 99 | STAT3_23295773_ChIP-Seq_U87_Human | 0.80114294 |
| 100 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.78762179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.85437725 |
| 2 | MP0002138_abnormal_hepatobiliary_system | 7.98003708 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.22439332 |
| 4 | MP0003195_calcinosis | 5.76625660 |
| 5 | MP0005365_abnormal_bile_salt | 5.31668702 |
| 6 | MP0003252_abnormal_bile_duct | 4.98199150 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.88958987 |
| 8 | MP0005360_urolithiasis | 3.68321780 |
| 9 | MP0010368_abnormal_lymphatic_system | 3.59114571 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.05347741 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.89938817 |
| 12 | MP0003868_abnormal_feces_composition | 2.73909930 |
| 13 | MP0002876_abnormal_thyroid_physiology | 2.09541862 |
| 14 | MP0001661_extended_life_span | 2.04436428 |
| 15 | MP0005332_abnormal_amino_acid | 1.84881155 |
| 16 | MP0000609_abnormal_liver_physiology | 1.68848832 |
| 17 | MP0003890_abnormal_embryonic-extraembry | 1.66113422 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 1.65091896 |
| 19 | MP0002254_reproductive_system_inflammat | 1.64416710 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.52100274 |
| 21 | MP0009697_abnormal_copulation | 1.40710650 |
| 22 | MP0005408_hypopigmentation | 1.38320623 |
| 23 | MP0001764_abnormal_homeostasis | 1.32398555 |
| 24 | MP0000604_amyloidosis | 1.27994230 |
| 25 | MP0000566_synostosis | 1.18949911 |
| 26 | MP0001915_intracranial_hemorrhage | 1.12609198 |
| 27 | MP0005187_abnormal_penis_morphology | 1.06834433 |
| 28 | MP0003690_abnormal_glial_cell | 1.06813933 |
| 29 | MP0002928_abnormal_bile_duct | 1.05561146 |
| 30 | MP0000598_abnormal_liver_morphology | 1.02252168 |
| 31 | MP0008057_abnormal_DNA_replication | 1.01407020 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 0.99497714 |
| 33 | MP0005670_abnormal_white_adipose | 0.97344821 |
| 34 | MP0005376_homeostasis/metabolism_phenot | 0.93001649 |
| 35 | MP0002971_abnormal_brown_adipose | 0.91268341 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 0.90243404 |
| 37 | MP0009840_abnormal_foam_cell | 0.88889448 |
| 38 | MP0004133_heterotaxia | 0.88523513 |
| 39 | MP0005647_abnormal_sex_gland | 0.86037700 |
| 40 | MP0003943_abnormal_hepatobiliary_system | 0.85142547 |
| 41 | MP0003011_delayed_dark_adaptation | 0.80440281 |
| 42 | MP0005220_abnormal_exocrine_pancreas | 0.78210980 |
| 43 | MP0009642_abnormal_blood_homeostasis | 0.77451978 |
| 44 | MP0005164_abnormal_response_to | 0.77123590 |
| 45 | MP0002168_other_aberrant_phenotype | 0.76836860 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 0.74458679 |
| 47 | MP0001879_abnormal_lymphatic_vessel | 0.73837247 |
| 48 | MP0008469_abnormal_protein_level | 0.73057888 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71261592 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 0.69724650 |
| 51 | MP0005266_abnormal_metabolism | 0.67820015 |
| 52 | MP0005395_other_phenotype | 0.67727889 |
| 53 | MP0004883_abnormal_blood_vessel | 0.65815302 |
| 54 | MP0003950_abnormal_plasma_membrane | 0.63320251 |
| 55 | MP0005451_abnormal_body_composition | 0.63027662 |
| 56 | MP0005636_abnormal_mineral_homeostasis | 0.62938369 |
| 57 | MP0009643_abnormal_urine_homeostasis | 0.59563938 |
| 58 | MP0001346_abnormal_lacrimal_gland | 0.56812154 |
| 59 | MP0005334_abnormal_fat_pad | 0.55877137 |
| 60 | MP0009115_abnormal_fat_cell | 0.55848777 |
| 61 | MP0001944_abnormal_pancreas_morphology | 0.55708299 |
| 62 | MP0005535_abnormal_body_temperature | 0.55597788 |
| 63 | MP0003632_abnormal_nervous_system | 0.55194967 |
| 64 | MP0004272_abnormal_basement_membrane | 0.52649646 |
| 65 | MP0003959_abnormal_lean_body | 0.52473618 |
| 66 | MP0003646_muscle_fatigue | 0.50708117 |
| 67 | MP0001919_abnormal_reproductive_system | 0.50698392 |
| 68 | MP0002132_abnormal_respiratory_system | 0.48102116 |
| 69 | MP0001324_abnormal_eye_pigmentation | 0.47342115 |
| 70 | MP0009763_increased_sensitivity_to | 0.47213457 |
| 71 | MP0003953_abnormal_hormone_level | 0.45611917 |
| 72 | MP0003638_abnormal_response/metabolism_ | 0.45252259 |
| 73 | MP0000920_abnormal_myelination | 0.44022031 |
| 74 | MP0004130_abnormal_muscle_cell | 0.43834049 |
| 75 | MP0005464_abnormal_platelet_physiology | 0.41842307 |
| 76 | MP0004233_abnormal_muscle_weight | 0.40688459 |
| 77 | MP0005084_abnormal_gallbladder_morpholo | 0.40271774 |
| 78 | MP0004147_increased_porphyrin_level | 0.38248523 |
| 79 | MP0002089_abnormal_postnatal_growth/wei | 0.38018737 |
| 80 | MP0005379_endocrine/exocrine_gland_phen | 0.37646137 |
| 81 | MP0002938_white_spotting | 0.36092177 |
| 82 | MP0000569_abnormal_digit_pigmentation | 0.35682417 |
| 83 | MP0003186_abnormal_redox_activity | 0.34489054 |
| 84 | MP0003633_abnormal_nervous_system | 0.34058732 |
| 85 | MP0003183_abnormal_peptide_metabolism | 0.31074964 |
| 86 | MP0003122_maternal_imprinting | 0.30585968 |
| 87 | MP0003699_abnormal_female_reproductive | 0.30523641 |
| 88 | MP0002697_abnormal_eye_size | 0.28995849 |
| 89 | MP0002128_abnormal_blood_circulation | 0.28504566 |
| 90 | MP0000249_abnormal_blood_vessel | 0.27034833 |
| 91 | MP0005023_abnormal_wound_healing | 0.26945680 |
| 92 | MP0003631_nervous_system_phenotype | 0.26781618 |
| 93 | MP0003123_paternal_imprinting | 0.25731370 |
| 94 | MP0000639_abnormal_adrenal_gland | 0.25109939 |
| 95 | MP0008961_abnormal_basal_metabolism | 0.24360338 |
| 96 | MP0005551_abnormal_eye_electrophysiolog | 0.23838700 |
| 97 | MP0004924_abnormal_behavior | 0.23823046 |
| 98 | MP0005386_behavior/neurological_phenoty | 0.23823046 |
| 99 | MP0005197_abnormal_uvea_morphology | 0.23591983 |
| 100 | MP0006276_abnormal_autonomic_nervous | 0.23041040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.78846244 |
| 2 | Abnormality of complement system (HP:0005339) | 7.76674033 |
| 3 | Conjugated hyperbilirubinemia (HP:0002908) | 6.99773930 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.66592378 |
| 5 | Glomerulonephritis (HP:0000099) | 6.58981072 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 6.13042591 |
| 7 | Abnormality of the common coagulation pathway (HP:0010990) | 5.78299824 |
| 8 | Joint hemorrhage (HP:0005261) | 5.76954776 |
| 9 | Abnormality of pyrimidine metabolism (HP:0004353) | 5.72476008 |
| 10 | Osteomalacia (HP:0002749) | 5.37351207 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 4.94931270 |
| 12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.64842167 |
| 13 | Fat malabsorption (HP:0002630) | 4.52107785 |
| 14 | Generalized aminoaciduria (HP:0002909) | 4.51954957 |
| 15 | Spontaneous abortion (HP:0005268) | 4.45164140 |
| 16 | Xanthomatosis (HP:0000991) | 4.25433399 |
| 17 | Nephritis (HP:0000123) | 4.02924919 |
| 18 | Abnormality of the intrinsic pathway (HP:0010989) | 3.98488262 |
| 19 | Hypolipoproteinemia (HP:0010981) | 3.73137067 |
| 20 | Hypercholesterolemia (HP:0003124) | 3.39413305 |
| 21 | Steatorrhea (HP:0002570) | 3.38660620 |
| 22 | Abnormality of nucleobase metabolism (HP:0010932) | 3.37779152 |
| 23 | Rickets (HP:0002748) | 3.34072969 |
| 24 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.15049781 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.04146406 |
| 26 | Abnormal biliary tract physiology (HP:0012439) | 3.03671298 |
| 27 | Bile duct proliferation (HP:0001408) | 3.03671298 |
| 28 | Arthropathy (HP:0003040) | 2.99846344 |
| 29 | Menorrhagia (HP:0000132) | 2.83158680 |
| 30 | Hepatocellular carcinoma (HP:0001402) | 2.77628697 |
| 31 | Gingival bleeding (HP:0000225) | 2.73002710 |
| 32 | Acanthocytosis (HP:0001927) | 2.61239997 |
| 33 | Vascular calcification (HP:0004934) | 2.59980025 |
| 34 | Hyperlipoproteinemia (HP:0010980) | 2.56315498 |
| 35 | Hyperammonemia (HP:0001987) | 2.47777675 |
| 36 | Abnormality of vitamin metabolism (HP:0100508) | 2.47169840 |
| 37 | Epidermoid cyst (HP:0200040) | 2.44953630 |
| 38 | Hyperphosphaturia (HP:0003109) | 2.44523442 |
| 39 | Delayed CNS myelination (HP:0002188) | 2.42508231 |
| 40 | Hypophosphatemic rickets (HP:0004912) | 2.41132918 |
| 41 | Elevated alkaline phosphatase (HP:0003155) | 2.39879485 |
| 42 | Decreased subcutaneous fat (HP:0001002) | 2.39374090 |
| 43 | Cholelithiasis (HP:0001081) | 2.34079355 |
| 44 | Abnormality of purine metabolism (HP:0004352) | 2.30209760 |
| 45 | Increased serum ferritin (HP:0003281) | 2.28812883 |
| 46 | Cardiovascular calcification (HP:0011915) | 2.26123510 |
| 47 | Hyperbilirubinemia (HP:0002904) | 2.20949117 |
| 48 | Scanning speech (HP:0002168) | 2.20756064 |
| 49 | Abnormal gallbladder morphology (HP:0012437) | 2.18592902 |
| 50 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.16721982 |
| 51 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.13448835 |
| 52 | Hypoalphalipoproteinemia (HP:0003233) | 2.11688918 |
| 53 | Abnormality of urine glucose concentration (HP:0011016) | 2.11278124 |
| 54 | Glycosuria (HP:0003076) | 2.11278124 |
| 55 | Abnormality of methionine metabolism (HP:0010901) | 2.09116270 |
| 56 | Poikilocytosis (HP:0004447) | 2.06864659 |
| 57 | Cholecystitis (HP:0001082) | 2.03448090 |
| 58 | Abnormal gallbladder physiology (HP:0012438) | 2.03448090 |
| 59 | Mitral stenosis (HP:0001718) | 2.00559079 |
| 60 | Deep venous thrombosis (HP:0002625) | 11.4276460 |
| 61 | Complement deficiency (HP:0004431) | 10.1687220 |
| 62 | Prolonged partial thromboplastin time (HP:0003645) | 10.0462952 |
| 63 | Abnormality of iron homeostasis (HP:0011031) | 1.98305320 |
| 64 | Sensorimotor neuropathy (HP:0007141) | 1.98259622 |
| 65 | Abnormal tarsal ossification (HP:0008369) | 1.96951522 |
| 66 | Fair hair (HP:0002286) | 1.96731561 |
| 67 | Thrombophlebitis (HP:0004418) | 1.93329595 |
| 68 | Myocardial infarction (HP:0001658) | 1.93078458 |
| 69 | Abnormal urine phosphate concentration (HP:0012599) | 1.92680629 |
| 70 | Peritonitis (HP:0002586) | 1.90231590 |
| 71 | Decreased muscle mass (HP:0003199) | 1.89912097 |
| 72 | Enlarged kidneys (HP:0000105) | 1.89157658 |
| 73 | Wrist flexion contracture (HP:0001239) | 1.87668938 |
| 74 | Purpura (HP:0000979) | 1.86298237 |
| 75 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85203275 |
| 76 | Bifid scrotum (HP:0000048) | 1.83494106 |
| 77 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.81768494 |
| 78 | Hypophosphatemia (HP:0002148) | 1.78818164 |
| 79 | Toxemia of pregnancy (HP:0100603) | 1.78012114 |
| 80 | Hyperglycinemia (HP:0002154) | 1.74674727 |
| 81 | Hemorrhage of the eye (HP:0011885) | 1.72927838 |
| 82 | Gastrointestinal infarctions (HP:0005244) | 1.72475720 |
| 83 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.70820494 |
| 84 | Anorexia (HP:0002039) | 1.63465174 |
| 85 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.61725406 |
| 86 | Joint swelling (HP:0001386) | 1.58142265 |
| 87 | Acute hepatic failure (HP:0006554) | 1.57418242 |
| 88 | Neoplasm of the liver (HP:0002896) | 1.57296431 |
| 89 | Epistaxis (HP:0000421) | 1.56972317 |
| 90 | Seborrheic dermatitis (HP:0001051) | 1.56196699 |
| 91 | Reduced antithrombin III activity (HP:0001976) | 1.55933651 |
| 92 | Gout (HP:0001997) | 1.54325567 |
| 93 | Hyperglycinuria (HP:0003108) | 1.53623511 |
| 94 | Abnormality of serum amino acid levels (HP:0003112) | 1.52936966 |
| 95 | Proximal tubulopathy (HP:0000114) | 1.52928468 |
| 96 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.52840802 |
| 97 | Abnormality of glycine metabolism (HP:0010895) | 1.52840802 |
| 98 | Abnormal foot bone ossification (HP:0010675) | 1.50808727 |
| 99 | Skin nodule (HP:0200036) | 1.45598779 |
| 100 | Increased mean platelet volume (HP:0011877) | 1.41721343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 5.59091915 |
| 2 | FRK | 4.94800427 |
| 3 | PIK3CA | 3.34442828 |
| 4 | TAF1 | 2.87039258 |
| 5 | BRSK2 | 2.76673165 |
| 6 | WNK3 | 2.69196865 |
| 7 | PIK3CG | 2.57162108 |
| 8 | TAOK3 | 2.47844397 |
| 9 | AKT3 | 2.25342791 |
| 10 | GRK1 | 1.96074288 |
| 11 | CAMK1G | 1.92652514 |
| 12 | CAMKK2 | 1.85784415 |
| 13 | NEK9 | 1.85624563 |
| 14 | PNCK | 1.81260926 |
| 15 | PRKAA2 | 1.74851625 |
| 16 | NLK | 1.73320190 |
| 17 | FGFR4 | 1.71698523 |
| 18 | CAMK1D | 1.65264594 |
| 19 | STK38 | 1.60375805 |
| 20 | RIPK1 | 1.58171956 |
| 21 | FGFR2 | 1.50418868 |
| 22 | FGFR3 | 1.50389047 |
| 23 | CDK19 | 1.45164500 |
| 24 | MAP3K2 | 1.44559028 |
| 25 | WNK1 | 1.42020048 |
| 26 | CDK3 | 1.40793315 |
| 27 | PINK1 | 1.38226671 |
| 28 | PRKACG | 1.37947492 |
| 29 | WNK4 | 1.30792847 |
| 30 | BCR | 1.22444410 |
| 31 | JAK2 | 1.20975113 |
| 32 | PRKAA1 | 1.15592435 |
| 33 | PAK3 | 1.14584595 |
| 34 | NTRK3 | 1.13652663 |
| 35 | CHUK | 1.12327048 |
| 36 | PRKCG | 1.10831804 |
| 37 | ERBB4 | 1.06875027 |
| 38 | CSNK1E | 1.05415962 |
| 39 | EPHA3 | 1.03632715 |
| 40 | MAPK11 | 1.02955460 |
| 41 | YES1 | 0.98924427 |
| 42 | IGF1R | 0.85965004 |
| 43 | MUSK | 0.84375778 |
| 44 | KSR2 | 0.84316357 |
| 45 | EIF2AK1 | 0.80844680 |
| 46 | MAP3K4 | 0.78813642 |
| 47 | NEK1 | 0.78293199 |
| 48 | INSRR | 0.77125429 |
| 49 | MAP4K2 | 0.75502400 |
| 50 | DYRK1B | 0.74207252 |
| 51 | SGK223 | 0.72542015 |
| 52 | SGK494 | 0.72542015 |
| 53 | SCYL2 | 0.71578153 |
| 54 | TYK2 | 0.71276584 |
| 55 | CDK12 | 0.68272653 |
| 56 | ICK | 0.67885475 |
| 57 | BMPR1B | 0.67731678 |
| 58 | PRKG1 | 0.66963343 |
| 59 | JAK1 | 0.65282832 |
| 60 | CSNK1D | 0.62316800 |
| 61 | BRSK1 | 0.62214190 |
| 62 | FGFR1 | 0.60474705 |
| 63 | RPS6KB1 | 0.60305685 |
| 64 | LATS1 | 0.60081482 |
| 65 | MAP2K7 | 0.60017130 |
| 66 | PRKCB | 0.59962436 |
| 67 | PRKACB | 0.58047968 |
| 68 | KSR1 | 0.57295085 |
| 69 | PRKACA | 0.56376679 |
| 70 | FER | 0.56238785 |
| 71 | SGK2 | 0.55343268 |
| 72 | MTOR | 0.52099461 |
| 73 | STK11 | 0.52058015 |
| 74 | CAMK4 | 0.51563502 |
| 75 | PBK | 0.51123471 |
| 76 | ERBB2 | 0.50584499 |
| 77 | RPS6KA3 | 0.49688223 |
| 78 | SGK1 | 0.48410151 |
| 79 | PRKCZ | 0.48222408 |
| 80 | MAP2K1 | 0.48111286 |
| 81 | IRAK3 | 0.46217212 |
| 82 | CDK6 | 0.45586634 |
| 83 | MKNK2 | 0.44997383 |
| 84 | CSNK2A1 | 0.44271297 |
| 85 | CSF1R | 0.43680328 |
| 86 | CSNK2A2 | 0.42736921 |
| 87 | MST4 | 0.41762693 |
| 88 | FLT3 | 0.41648151 |
| 89 | ERN1 | 0.40118972 |
| 90 | RET | 0.40004783 |
| 91 | PRKCE | 0.39754049 |
| 92 | BRD4 | 0.39244581 |
| 93 | MAPK14 | 0.38378721 |
| 94 | CASK | 0.37732134 |
| 95 | PDPK1 | 0.37605473 |
| 96 | ADRBK2 | 0.34584297 |
| 97 | MAP2K4 | 0.33354751 |
| 98 | MAPK1 | 0.33079179 |
| 99 | OBSCN | 0.32722205 |
| 100 | PDK1 | 0.32282658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.78454772 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.32247617 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.91577836 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.87021510 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 3.32331715 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.27323386 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.17927114 |
| 8 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.96441324 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.90279944 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.80398030 |
| 11 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.60848675 |
| 12 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.49891210 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.28127443 |
| 14 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.18804862 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.10995691 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00441039 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.92798189 |
| 18 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.92079599 |
| 19 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.91847680 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.91244146 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.89151547 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.86427530 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85486304 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.81222239 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.77783555 |
| 26 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.75938676 |
| 27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.72335324 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.62884327 |
| 29 | ABC transporters_Homo sapiens_hsa02010 | 1.41975661 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.35207987 |
| 31 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.30522620 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.29769191 |
| 33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26762398 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19433100 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.19288629 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.18733206 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.18697262 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.15513075 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12431530 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01127820 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.96785954 |
| 42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.93962714 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.93955429 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90631185 |
| 45 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83906089 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83372772 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82763996 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81003217 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.78978741 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75242462 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.72056070 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67108165 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.54416922 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53562226 |
| 55 | Insulin resistance_Homo sapiens_hsa04931 | 0.51742179 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.50542578 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.45681396 |
| 58 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44482630 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42511023 |
| 60 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38568096 |
| 61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.38450032 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37803622 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.37298106 |
| 64 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.34998860 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34566214 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.33767027 |
| 67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32327923 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31915685 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.31771091 |
| 70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.30878958 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27770003 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.24091854 |
| 73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.23639627 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.23018051 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.20021388 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18168029 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.16727266 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.16665122 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.15408628 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15105541 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.13059412 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.10149121 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.09960621 |
| 84 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.08636693 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.08095234 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.03257903 |
| 87 | Circadian entrainment_Homo sapiens_hsa04713 | 0.02016276 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1617058 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | -0.1395454 |
| 90 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1298456 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | -0.1266270 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1078232 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | -0.0811086 |
| 94 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0760852 |
| 95 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0688589 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0677958 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0603930 |
| 98 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0530993 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0454244 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | -0.0421698 |

